Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Overweight × Exercise × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 6 Breast 2 Other hematologic neoplasm 1 Lymphoid 1 Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 5 Obesity 4 Motor Activity 2 Sexual Dysfunction, Physiological 1 Overweight 1 Limb-girdle muscular dystrophy, type 2C 1 Inflammation 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

Sucrose 1 Exercise 1 Diet 1 Aspartame 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05311800 2023-02-24

RIESLING

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Phase NA Completed

Obesity, Multiple Endocrine Neoplasia Type 1, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡